

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 8.92977946 |
| 2 | complement activation, classical pathway (GO:0006958) | 8.85813324 |
| 3 | glomerular filtration (GO:0003094) | 7.25489092 |
| 4 | complement activation (GO:0006956) | 7.01268340 |
| 5 | renal filtration (GO:0097205) | 6.54229861 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.25030081 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.24308400 |
| 8 | regulation of respiratory burst (GO:0060263) | 5.96532038 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.94700626 |
| 10 | antibacterial humoral response (GO:0019731) | 5.68107947 |
| 11 | antimicrobial humoral response (GO:0019730) | 5.57481248 |
| 12 | protein activation cascade (GO:0072376) | 5.15178196 |
| 13 | regulation of cellular extravasation (GO:0002691) | 4.89258448 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.63712313 |
| 15 | humoral immune response (GO:0006959) | 4.58668966 |
| 16 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.45082201 |
| 17 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.45082201 |
| 18 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.45082201 |
| 19 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.42562376 |
| 20 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.20232207 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.07856828 |
| 22 | detection of bacterium (GO:0016045) | 3.97148052 |
| 23 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.94306709 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.84795087 |
| 25 | detection of other organism (GO:0098543) | 3.80584248 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.80239266 |
| 27 | negative regulation of cell killing (GO:0031342) | 3.80239266 |
| 28 | positive regulation of pseudopodium assembly (GO:0031274) | 3.79638726 |
| 29 | regulation of antigen processing and presentation (GO:0002577) | 3.71173516 |
| 30 | angiotensin maturation (GO:0002003) | 3.65167965 |
| 31 | retina homeostasis (GO:0001895) | 3.57197872 |
| 32 | response to type I interferon (GO:0034340) | 3.56237318 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.55146141 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.55146141 |
| 35 | germinal center formation (GO:0002467) | 3.50692900 |
| 36 | regulation of pseudopodium assembly (GO:0031272) | 3.38197988 |
| 37 | positive regulation of antigen processing and presentation (GO:0002579) | 3.31830946 |
| 38 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.30451642 |
| 39 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.29066452 |
| 40 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.26887545 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20947570 |
| 42 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.19730192 |
| 43 | cellular response to interferon-gamma (GO:0071346) | 3.18810275 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.18616352 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 3.14486733 |
| 46 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.10411687 |
| 47 | regulation of guanylate cyclase activity (GO:0031282) | 3.04490954 |
| 48 | intestinal absorption (GO:0050892) | 3.03888331 |
| 49 | B cell mediated immunity (GO:0019724) | 3.03803764 |
| 50 | GDP-mannose metabolic process (GO:0019673) | 3.02018731 |
| 51 | eosinophil chemotaxis (GO:0048245) | 2.99792634 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99563845 |
| 53 | response to interferon-gamma (GO:0034341) | 2.97379001 |
| 54 | production of molecular mediator of immune response (GO:0002440) | 2.97063287 |
| 55 | negative regulation of myotube differentiation (GO:0010832) | 2.88738812 |
| 56 | regulation of necrotic cell death (GO:0010939) | 2.87384210 |
| 57 | positive regulation of Rap GTPase activity (GO:0032854) | 2.86749844 |
| 58 | oligosaccharide biosynthetic process (GO:0009312) | 2.86535708 |
| 59 | myeloid dendritic cell differentiation (GO:0043011) | 2.82390081 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 2.81856559 |
| 61 | chronic inflammatory response (GO:0002544) | 2.80173578 |
| 62 | T cell costimulation (GO:0031295) | 2.78092776 |
| 63 | T-helper 1 type immune response (GO:0042088) | 2.73928032 |
| 64 | lymphocyte costimulation (GO:0031294) | 2.73871067 |
| 65 | detection of external biotic stimulus (GO:0098581) | 2.73412138 |
| 66 | eosinophil migration (GO:0072677) | 2.71946073 |
| 67 | dendritic cell chemotaxis (GO:0002407) | 2.71667232 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 2.70756265 |
| 69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.69901951 |
| 70 | defense response to protozoan (GO:0042832) | 2.69049174 |
| 71 | regulation of integrin activation (GO:0033623) | 2.68569378 |
| 72 | regulation of vitamin metabolic process (GO:0030656) | 2.64255323 |
| 73 | positive thymic T cell selection (GO:0045059) | 2.62524245 |
| 74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.61113104 |
| 75 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.55788176 |
| 76 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55788176 |
| 77 | modulation by symbiont of host immune response (GO:0052553) | 2.55788176 |
| 78 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55788176 |
| 79 | modulation by symbiont of host defense response (GO:0052031) | 2.55788176 |
| 80 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55788176 |
| 81 | regulation of regulatory T cell differentiation (GO:0045589) | 2.55400069 |
| 82 | immune response-activating signal transduction (GO:0002757) | 2.52336066 |
| 83 | peptide catabolic process (GO:0043171) | 2.52074296 |
| 84 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.49492974 |
| 85 | interferon-gamma secretion (GO:0072643) | 2.45571029 |
| 86 | activation of immune response (GO:0002253) | 2.45369152 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.43933395 |
| 88 | B cell homeostasis (GO:0001782) | 2.42801527 |
| 89 | positive regulation of type 2 immune response (GO:0002830) | 2.42311011 |
| 90 | T cell migration (GO:0072678) | 2.41045900 |
| 91 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.38636665 |
| 92 | dendritic cell migration (GO:0036336) | 2.38554174 |
| 93 | macrophage activation involved in immune response (GO:0002281) | 2.38434050 |
| 94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.37935300 |
| 95 | adhesion of symbiont to host cell (GO:0044650) | 2.37232074 |
| 96 | virion attachment to host cell (GO:0019062) | 2.37232074 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 2.36039151 |
| 98 | respiratory burst (GO:0045730) | 2.35747787 |
| 99 | protein-chromophore linkage (GO:0018298) | 2.34778819 |
| 100 | positive regulation of B cell differentiation (GO:0045579) | 2.32925684 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.18996653 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.83058231 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.01397192 |
| 4 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.15489086 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.07372068 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.83592615 |
| 7 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.63006154 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.48613978 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.45493031 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30216635 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26201785 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.25998253 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22834999 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14640500 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09021909 |
| 16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07070411 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04144915 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01748013 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00925880 |
| 20 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.91125301 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86559615 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86168306 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82417319 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78375778 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72958385 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72384831 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68600187 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68310465 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.67227744 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63327670 |
| 31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.59166626 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.59063513 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56016796 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.49795839 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49228003 |
| 36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.47789755 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47763756 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44519979 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43570232 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.40144501 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.39847771 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39719630 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36543066 |
| 44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36501296 |
| 45 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35291496 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.35099212 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34205477 |
| 48 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33014632 |
| 49 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.32928035 |
| 50 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.32350830 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31786919 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30457498 |
| 53 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29056793 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28948110 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28879417 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27947799 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27071189 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26053955 |
| 59 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25753651 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24756727 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23270141 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22605036 |
| 63 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20532195 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19925255 |
| 65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18333624 |
| 66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.18139107 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16605081 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16045326 |
| 69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.14289922 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13944202 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.12211446 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11968916 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10797115 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.08294142 |
| 75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.07662802 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06594588 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06428338 |
| 78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06242080 |
| 79 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05687412 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04933798 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04931668 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04445215 |
| 83 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.03901038 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03552521 |
| 85 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01669549 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99326313 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99096068 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99000042 |
| 89 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98581139 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98183483 |
| 91 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92577736 |
| 92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91155333 |
| 93 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90912585 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90173408 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88959734 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88744993 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87930835 |
| 98 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87868932 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86680539 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85773568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 3.67967420 |
| 2 | MP0003303_peritoneal_inflammation | 3.49982518 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.37983103 |
| 4 | MP0010155_abnormal_intestine_physiology | 3.34019826 |
| 5 | MP0005387_immune_system_phenotype | 3.14508400 |
| 6 | MP0001790_abnormal_immune_system | 3.14508400 |
| 7 | MP0003436_decreased_susceptibility_to | 2.93868802 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.91110810 |
| 9 | MP0001800_abnormal_humoral_immune | 2.76031782 |
| 10 | MP0001873_stomach_inflammation | 2.56982020 |
| 11 | MP0000685_abnormal_immune_system | 2.53183278 |
| 12 | MP0005671_abnormal_response_to | 2.48688504 |
| 13 | MP0005025_abnormal_response_to | 2.47676558 |
| 14 | MP0003866_abnormal_defecation | 2.43629778 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.41679572 |
| 16 | MP0009785_altered_susceptibility_to | 2.33771991 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.29177230 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.19440998 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.12067901 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.01079083 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.00957763 |
| 22 | MP0005166_decreased_susceptibility_to | 1.99066633 |
| 23 | MP0000465_gastrointestinal_hemorrhage | 1.97370194 |
| 24 | MP0002723_abnormal_immune_serum | 1.96967527 |
| 25 | MP0001819_abnormal_immune_cell | 1.92568842 |
| 26 | MP0001663_abnormal_digestive_system | 1.92551011 |
| 27 | MP0005360_urolithiasis | 1.91424702 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.91289223 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.90925062 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.89357424 |
| 31 | MP0002419_abnormal_innate_immunity | 1.83909033 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.83095452 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.82423447 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.78385620 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.75064240 |
| 36 | MP0004947_skin_inflammation | 1.70918547 |
| 37 | MP0004858_abnormal_nervous_system | 1.70143355 |
| 38 | MP0006082_CNS_inflammation | 1.69066806 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.63198194 |
| 40 | MP0004782_abnormal_surfactant_physiolog | 1.62473765 |
| 41 | MP0005310_abnormal_salivary_gland | 1.61723889 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.61309736 |
| 43 | MP0000490_abnormal_crypts_of | 1.53164548 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.51008648 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.46557735 |
| 46 | MP0005381_digestive/alimentary_phenotyp | 1.45906039 |
| 47 | MP0000716_abnormal_immune_system | 1.41908598 |
| 48 | MP0009840_abnormal_foam_cell | 1.38363823 |
| 49 | MP0000477_abnormal_intestine_morphology | 1.37744057 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.29810447 |
| 51 | MP0002006_tumorigenesis | 1.28386113 |
| 52 | MP0002398_abnormal_bone_marrow | 1.27951263 |
| 53 | MP0005451_abnormal_body_composition | 1.25645379 |
| 54 | MP0002876_abnormal_thyroid_physiology | 1.23352782 |
| 55 | MP0003868_abnormal_feces_composition | 1.19397602 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.19136717 |
| 57 | MP0001664_abnormal_digestion | 1.18377798 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.16530992 |
| 59 | MP0000604_amyloidosis | 1.13627084 |
| 60 | MP0003075_altered_response_to | 1.12596221 |
| 61 | MP0008469_abnormal_protein_level | 1.11300222 |
| 62 | MP0002429_abnormal_blood_cell | 1.11155191 |
| 63 | MP0002405_respiratory_system_inflammati | 1.10943713 |
| 64 | MP0003045_fibrosis | 1.10615912 |
| 65 | MP0002933_joint_inflammation | 1.08125578 |
| 66 | MP0003448_altered_tumor_morphology | 1.04979244 |
| 67 | MP0009379_abnormal_foot_pigmentation | 1.04041203 |
| 68 | MP0008004_abnormal_stomach_pH | 1.03982852 |
| 69 | MP0005275_abnormal_skin_tensile | 1.02710231 |
| 70 | MP0003329_amyloid_beta_deposits | 1.02661504 |
| 71 | MP0005365_abnormal_bile_salt | 1.00212467 |
| 72 | MP0000689_abnormal_spleen_morphology | 0.98845935 |
| 73 | MP0002722_abnormal_immune_system | 0.98540712 |
| 74 | MP0009764_decreased_sensitivity_to | 0.98449446 |
| 75 | MP0000858_altered_metastatic_potential | 0.97241556 |
| 76 | MP0005023_abnormal_wound_healing | 0.96343482 |
| 77 | MP0000249_abnormal_blood_vessel | 0.95471641 |
| 78 | MP0002796_impaired_skin_barrier | 0.95444709 |
| 79 | MP0000343_altered_response_to | 0.93190851 |
| 80 | MP0004510_myositis | 0.90066195 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.88497176 |
| 82 | MP0004043_abnormal_pH_regulation | 0.87788092 |
| 83 | MP0005390_skeleton_phenotype | 0.81763854 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.81628863 |
| 85 | MP0005058_abnormal_lysosome_morphology | 0.81475729 |
| 86 | MP0002396_abnormal_hematopoietic_system | 0.80600470 |
| 87 | MP0005409_darkened_coat_color | 0.80526089 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 0.78538642 |
| 89 | MP0003091_abnormal_cell_migration | 0.78141183 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.77001677 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.75662336 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.73536696 |
| 93 | MP0008260_abnormal_autophagy | 0.73069816 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 0.72822250 |
| 95 | MP0005165_increased_susceptibility_to | 0.71582397 |
| 96 | MP0003252_abnormal_bile_duct | 0.69478295 |
| 97 | MP0001851_eye_inflammation | 0.69186040 |
| 98 | MP0003795_abnormal_bone_structure | 0.68842225 |
| 99 | MP0005164_abnormal_response_to | 0.67527349 |
| 100 | MP0003279_aneurysm | 0.66577199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.86091084 |
| 2 | Malnutrition (HP:0004395) | 4.95284340 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.64132897 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.34825098 |
| 5 | Colitis (HP:0002583) | 4.31952520 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.21871865 |
| 7 | Gastrointestinal stroma tumor (HP:0100723) | 3.95536981 |
| 8 | Vasculitis (HP:0002633) | 3.84614957 |
| 9 | Hyperactive renin-angiotensin system (HP:0000841) | 3.67012179 |
| 10 | Prostate neoplasm (HP:0100787) | 3.63493690 |
| 11 | Glomerulonephritis (HP:0000099) | 3.62834435 |
| 12 | Abnormality of complement system (HP:0005339) | 3.59775873 |
| 13 | Inflammation of the large intestine (HP:0002037) | 3.54292244 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49706707 |
| 15 | Meningitis (HP:0001287) | 3.48937678 |
| 16 | Chronic diarrhea (HP:0002028) | 3.43092470 |
| 17 | Recurrent bronchitis (HP:0002837) | 3.42920441 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 3.38931103 |
| 19 | Complement deficiency (HP:0004431) | 3.33239311 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.26902728 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.21495667 |
| 22 | Abnormality of the prostate (HP:0008775) | 3.20416848 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.18546004 |
| 24 | Cellulitis (HP:0100658) | 3.17314893 |
| 25 | Metabolic alkalosis (HP:0200114) | 3.16645471 |
| 26 | Recurrent sinusitis (HP:0011108) | 3.14721480 |
| 27 | Decreased circulating renin level (HP:0003351) | 3.14258207 |
| 28 | Recurrent viral infections (HP:0004429) | 3.07436583 |
| 29 | Recurrent bacterial skin infections (HP:0005406) | 3.06281507 |
| 30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.05996995 |
| 31 | Nephritis (HP:0000123) | 3.02728901 |
| 32 | Recurrent abscess formation (HP:0002722) | 3.01623761 |
| 33 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.00756023 |
| 34 | Villous atrophy (HP:0011473) | 3.00756023 |
| 35 | Premature loss of primary teeth (HP:0006323) | 2.90446861 |
| 36 | Emphysema (HP:0002097) | 2.86223785 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 2.86169391 |
| 38 | Osteomyelitis (HP:0002754) | 2.80657038 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.79618298 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.79534179 |
| 41 | Skin rash (HP:0000988) | 2.77518155 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.77078793 |
| 43 | Alkalosis (HP:0001948) | 2.71681075 |
| 44 | Chronic otitis media (HP:0000389) | 2.69080555 |
| 45 | B lymphocytopenia (HP:0010976) | 2.68182088 |
| 46 | Increased IgE level (HP:0003212) | 2.68038296 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.67903785 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.67054897 |
| 49 | Hemoptysis (HP:0002105) | 2.61090563 |
| 50 | Myositis (HP:0100614) | 2.60245622 |
| 51 | Gingivitis (HP:0000230) | 2.58937483 |
| 52 | Obstructive lung disease (HP:0006536) | 2.58134699 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58134699 |
| 54 | Abnormality of renin-angiotensin system (HP:0000847) | 2.56549093 |
| 55 | Orchitis (HP:0100796) | 2.55601627 |
| 56 | Ileus (HP:0002595) | 2.54402722 |
| 57 | Urticaria (HP:0001025) | 2.51701758 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.51187631 |
| 59 | Leukocytosis (HP:0001974) | 2.42386648 |
| 60 | Restrictive lung disease (HP:0002091) | 2.41670022 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.40756850 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.40756850 |
| 63 | Recurrent pneumonia (HP:0006532) | 2.39630922 |
| 64 | Flat acetabular roof (HP:0003180) | 2.33996638 |
| 65 | Pustule (HP:0200039) | 2.33818354 |
| 66 | Recurrent skin infections (HP:0001581) | 2.32172994 |
| 67 | Recurrent lower respiratory tract infections (HP:0002783) | 2.30783062 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28159085 |
| 69 | Flattened epiphyses (HP:0003071) | 2.28058742 |
| 70 | Hematochezia (HP:0002573) | 2.27144156 |
| 71 | Lymphopenia (HP:0001888) | 2.26860806 |
| 72 | Papilloma (HP:0012740) | 2.26242216 |
| 73 | Verrucae (HP:0200043) | 2.26242216 |
| 74 | Hemorrhage of the eye (HP:0011885) | 2.24514656 |
| 75 | Autoimmune hemolytic anemia (HP:0001890) | 2.17597718 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.16855679 |
| 77 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.15589403 |
| 78 | IgM deficiency (HP:0002850) | 2.15286746 |
| 79 | Chest pain (HP:0100749) | 2.14218231 |
| 80 | Bronchitis (HP:0012387) | 2.13016869 |
| 81 | Nasal polyposis (HP:0100582) | 2.12551189 |
| 82 | Encephalitis (HP:0002383) | 2.12210397 |
| 83 | Right ventricular cardiomyopathy (HP:0011663) | 2.11819489 |
| 84 | Retrobulbar optic neuritis (HP:0100654) | 2.07327874 |
| 85 | Optic neuritis (HP:0100653) | 2.07327874 |
| 86 | IgA deficiency (HP:0002720) | 2.04883240 |
| 87 | Autoimmune thrombocytopenia (HP:0001973) | 2.03806630 |
| 88 | Abnormality of T cell number (HP:0011839) | 2.03133391 |
| 89 | Abnormality of T cells (HP:0002843) | 2.01107960 |
| 90 | Increased IgM level (HP:0003496) | 1.99747757 |
| 91 | Skin ulcer (HP:0200042) | 1.97765955 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 1.96218077 |
| 93 | Purpura (HP:0000979) | 1.91314903 |
| 94 | Abnormality of the pleura (HP:0002103) | 1.91256407 |
| 95 | Granulocytopenia (HP:0001913) | 1.89057642 |
| 96 | Abnormality of the peritoneum (HP:0002585) | 1.88630353 |
| 97 | Abnormal tarsal ossification (HP:0008369) | 1.87386598 |
| 98 | Abnormality of chloride homeostasis (HP:0011422) | 1.85099687 |
| 99 | Abnormality of male internal genitalia (HP:0000022) | 1.84560782 |
| 100 | Sepsis (HP:0100806) | 1.83760784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.47314826 |
| 2 | MAP4K1 | 4.02829689 |
| 3 | RIPK4 | 3.32689459 |
| 4 | TYK2 | 3.17462484 |
| 5 | MST1R | 2.96359400 |
| 6 | FGFR4 | 2.70384913 |
| 7 | BLK | 2.62457865 |
| 8 | ACVR1B | 2.46711630 |
| 9 | RIPK1 | 2.38785183 |
| 10 | PRPF4B | 2.33612749 |
| 11 | CDC42BPA | 2.08721915 |
| 12 | MAP3K10 | 2.04871936 |
| 13 | IKBKE | 1.84703695 |
| 14 | JAK1 | 1.84230128 |
| 15 | EPHA3 | 1.80955266 |
| 16 | PIK3CA | 1.80364150 |
| 17 | EPHB1 | 1.69405474 |
| 18 | IRAK4 | 1.66806468 |
| 19 | JAK3 | 1.64656500 |
| 20 | GRK6 | 1.62519146 |
| 21 | KIT | 1.62421850 |
| 22 | MAP3K14 | 1.60602904 |
| 23 | FGFR3 | 1.60032122 |
| 24 | TXK | 1.56415048 |
| 25 | TBK1 | 1.54134694 |
| 26 | ZAP70 | 1.47882300 |
| 27 | CSK | 1.45963795 |
| 28 | NME2 | 1.44459750 |
| 29 | SYK | 1.36422481 |
| 30 | EPHA2 | 1.34922545 |
| 31 | TRIB3 | 1.32193560 |
| 32 | BTK | 1.26298711 |
| 33 | STK24 | 1.24843681 |
| 34 | BMPR2 | 1.24806349 |
| 35 | JAK2 | 1.20680954 |
| 36 | LYN | 1.16988763 |
| 37 | PKN2 | 1.16837011 |
| 38 | FES | 1.16418508 |
| 39 | MAP3K1 | 1.15997838 |
| 40 | CSF1R | 1.13638900 |
| 41 | PRKG2 | 1.11976879 |
| 42 | MAP3K13 | 1.07950559 |
| 43 | PTK6 | 1.03821264 |
| 44 | MATK | 1.03613401 |
| 45 | IRAK1 | 1.03226048 |
| 46 | EPHB2 | 0.99032092 |
| 47 | MAPK11 | 0.97450368 |
| 48 | SIK3 | 0.94025352 |
| 49 | HCK | 0.91962273 |
| 50 | NLK | 0.88688764 |
| 51 | SMG1 | 0.88650269 |
| 52 | MAPK7 | 0.86028022 |
| 53 | IKBKB | 0.84808177 |
| 54 | TAOK1 | 0.83349081 |
| 55 | MET | 0.82202945 |
| 56 | DDR2 | 0.81580918 |
| 57 | LMTK2 | 0.80221088 |
| 58 | PDPK1 | 0.75022915 |
| 59 | LCK | 0.72089968 |
| 60 | OXSR1 | 0.71677301 |
| 61 | TESK2 | 0.70677616 |
| 62 | PDK1 | 0.69513081 |
| 63 | PDGFRA | 0.69244866 |
| 64 | MAP3K11 | 0.67916947 |
| 65 | ITK | 0.66305517 |
| 66 | FGR | 0.66043428 |
| 67 | MAP2K2 | 0.64399651 |
| 68 | MAP3K3 | 0.63143778 |
| 69 | TGFBR2 | 0.63036732 |
| 70 | RET | 0.61390648 |
| 71 | FER | 0.61331484 |
| 72 | PRKCQ | 0.61259433 |
| 73 | HIPK2 | 0.58969276 |
| 74 | TEC | 0.57927554 |
| 75 | STK39 | 0.52729628 |
| 76 | FYN | 0.50732356 |
| 77 | YES1 | 0.48432090 |
| 78 | SIK2 | 0.45685796 |
| 79 | MAPKAPK2 | 0.45375454 |
| 80 | MAP2K3 | 0.44873290 |
| 81 | MAPK4 | 0.43955294 |
| 82 | LRRK2 | 0.43885351 |
| 83 | CDK19 | 0.43836787 |
| 84 | MELK | 0.42966206 |
| 85 | TNK2 | 0.42653345 |
| 86 | TNIK | 0.42575787 |
| 87 | TAOK3 | 0.42147099 |
| 88 | BMX | 0.40988068 |
| 89 | PRKD2 | 0.39752751 |
| 90 | MYLK | 0.39660221 |
| 91 | MAPK12 | 0.38810188 |
| 92 | KSR2 | 0.37350080 |
| 93 | MAP3K2 | 0.35281152 |
| 94 | CHUK | 0.32623397 |
| 95 | SIK1 | 0.29947834 |
| 96 | PRKCD | 0.28914601 |
| 97 | SRC | 0.27531142 |
| 98 | PIM1 | 0.27343710 |
| 99 | MAP3K6 | 0.26775345 |
| 100 | NEK9 | 0.26178465 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.81106657 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.52360329 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.45121213 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.43397457 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.40202309 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.27812036 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.75264383 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.68396110 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48694599 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23125554 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20097612 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01638790 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96886774 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.96307086 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79165261 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.63102313 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60039909 |
| 18 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.57567918 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50722314 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50016428 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.37251143 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.36805867 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.36709039 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.35985769 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33467432 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.33190768 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30546763 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30207819 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.22115427 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21902708 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12625586 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11234445 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07430739 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05230160 |
| 35 | Mineral absorption_Homo sapiens_hsa04978 | 1.03667327 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99502507 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97458804 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 0.95365024 |
| 39 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.94851840 |
| 40 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90827693 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89290677 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 0.88144444 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83582657 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83459617 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77868550 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77230292 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76799408 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74867940 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.74035223 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72981519 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72062519 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70401445 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69427858 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68867663 |
| 55 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67150115 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65928069 |
| 57 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65068304 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64136878 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62966628 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62246156 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61707231 |
| 62 | Malaria_Homo sapiens_hsa05144 | 0.61567284 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59849988 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58940847 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56096780 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.53747158 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52933914 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52812253 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52555173 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 0.52171428 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51929826 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50144820 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49331469 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48091279 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47965908 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47522427 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45873502 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44943076 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.44431472 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43005207 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42686299 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41832995 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41160603 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39402033 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39118208 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.39103850 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.37956323 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.37737865 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.37342817 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35195525 |
| 91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33489119 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32071111 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31414337 |
| 94 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31362513 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30853412 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27166944 |
| 97 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.26304462 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25646754 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.25010866 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.24794421 |

